{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:59:11Z","timestamp":1793411951648,"version":"4.5.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007614","name":"Al Jouf University","doi-asserted-by":"publisher","award":["DSR-2021-01-0106"],"award-info":[{"award-number":["DSR-2021-01-0106"]}],"id":[{"id":"10.13039\/501100007614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.biopha.2022.112789","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T07:39:46Z","timestamp":1646638786000},"page":"112789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["The contribution of sterile inflammation to the fatty liver disease and the potential therapies"],"prefix":"10.1016","volume":"148","author":[{"given":"Mohamed E.","family":"Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2022.112789_bib1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/er.2008-0009","article-title":"Causes and metabolic consequences of fatty liver","volume":"29","author":"Stefan","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.biopha.2022.112789_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-nutr-072610-145138","article-title":"Inflammation in alcoholic liver disease","volume":"32","author":"Wang","year":"2012","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.biopha.2022.112789_bib3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006049","article-title":"Signaling in innate immunity and inflammation","volume":"4","author":"Newton","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: a clear and present danger","volume":"90","author":"Malhi","year":"2010","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: all we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.112789_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vetimm.2012.05.004","article-title":"Activation of the damage-associated molecular pattern receptor P2X7 induces interleukin-1beta release from canine monocytes","volume":"149","author":"Jalilian","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/emboj.2012.328","article-title":"TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis","volume":"32","author":"Nystrom","year":"2013","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib10","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"26","key":"10.1016\/j.biopha.2022.112789_bib11","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.biopha.2022.112789_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/853175","article-title":"Oxidative stress and inflammation: essential partners in alcoholic liver disease","volume":"2012","author":"Ambade","year":"2012","journal-title":"Int J. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib13","first-page":"277","article-title":"Alcohol, oxidative stress, and free radical damage","volume":"27","author":"Wu","year":"2003","journal-title":"Alcohol Res. Health"},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(96)06434-0","article-title":"Ethanol metabolism, cirrhosis and alcoholism","volume":"257","author":"Lieber","year":"1997","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.alcohol.2005.03.009","article-title":"DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis","volume":"35","author":"Brooks","year":"2005","journal-title":"Alcohol"},{"issue":"50","key":"10.1016\/j.biopha.2022.112789_bib16","doi-asserted-by":"crossref","first-page":"42165","DOI":"10.1074\/jbc.M112.377374","article-title":"Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterations","volume":"287","author":"Han","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib17","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1530-0277.2010.01399.x","article-title":"Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines","volume":"35","author":"Miller","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12263-009-0150-5","article-title":"CYP2E1 potentiation of LPS and TNFalpha-induced hepatotoxicity by mechanisms involving enhanced oxidative and nitrosative stress, activation of MAP kinases, and mitochondrial dysfunction","volume":"5","author":"Lu","year":"2010","journal-title":"Genes Nutr."},{"issue":"7","key":"10.1016\/j.biopha.2022.112789_bib20","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1053\/gast.2002.33613","article-title":"Alcohol and mitochondria: a dysfunctional relationship","volume":"122","author":"Hoek","year":"2002","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.biopha.2022.112789_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/apt.12046","article-title":"Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?","volume":"36","author":"Yilmaz","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/SMJ.0b013e3181de0ce0","article-title":"Nonalcoholic steatohepatitis: a review of the literature and updates in management","volume":"103","author":"Pasumarthy","year":"2010","journal-title":"South. Med. J."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib23","doi-asserted-by":"crossref","first-page":"G194","DOI":"10.1152\/ajpgi.00413.2005","article-title":"Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis","volume":"290","author":"Bradbury","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejim.2003.12.008","article-title":"Non-alcoholic steatohepatitis: review of a growing medical problem","volume":"15","author":"Te Sligte","year":"2004","journal-title":"Eur. J. Intern. Med."},{"issue":"10","key":"10.1016\/j.biopha.2022.112789_bib25","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.2337\/db11-0425","article-title":"Fatty acids, obesity, and insulin resistance: time for a reevaluation","volume":"60","author":"Karpe","year":"2011","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.20283","article-title":"Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway","volume":"40","author":"Feldstein","year":"2004","journal-title":"Hepatology"},{"issue":"29","key":"10.1016\/j.biopha.2022.112789_bib28","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.2174\/13816128113199990344","article-title":"Pathophysiology of NASH: perspectives for a targeted treatment","volume":"19","author":"Marra","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1189\/jlb.1105672","article-title":"New insights into the regulation of TLR signaling","volume":"80","author":"Miggin","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12017-009-8094-x","article-title":"A clear and present danger: endogenous ligands of Toll-like receptors","volume":"12","author":"Sloane","year":"2010","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.biopha.2022.112789_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-065X.2007.00579.x","article-title":"The grateful dead: damage-associated molecular pattern molecules and reduction\/oxidation regulate immunity","volume":"220","author":"Lotze","year":"2007","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2022.112789_bib33","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1017\/S0007114511004983","article-title":"Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis","volume":"107","author":"Wagnerberger","year":"2012","journal-title":"Br. J. Nutr."},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.21138","article-title":"Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver","volume":"43","author":"Gustot","year":"2006","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2022.112789_bib35","first-page":"S46","article-title":"Impaired receptor-mediated endocytosis: its role in alcohol-induced apoptosis","volume":"23","author":"Casey","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib36","first-page":"305","article-title":"Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome","volume":"119","author":"Imaeda","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"3 Pt 1","key":"10.1016\/j.biopha.2022.112789_bib37","doi-asserted-by":"crossref","first-page":"C577","DOI":"10.1152\/ajpcell.1993.265.3.C577","article-title":"Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides","volume":"265","author":"Dubyak","year":"1993","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib38","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2022.112789_bib39","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.4049\/jimmunol.180.11.7147","article-title":"P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage","volume":"180","author":"Pelegrin","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2006.08.002","article-title":"The inflammasome: first line of the immune response to cell stress","volume":"126","author":"Ogura","year":"2006","journal-title":"Cell"},{"issue":"6996","key":"10.1016\/j.biopha.2022.112789_bib41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature02664","article-title":"Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf","volume":"430","author":"Mariathasan","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2011.01043.x","article-title":"Sensing damage by the NLRP3 inflammasome","volume":"243","author":"Leemans","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2022.112789_bib43","doi-asserted-by":"crossref","first-page":"678627","DOI":"10.1155\/2013\/678627","article-title":"The NLRP3 inflammasome as a novel player of the intercellular crosstalk in metabolic disorders","volume":"2013","author":"Benetti","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib44","doi-asserted-by":"crossref","first-page":"G1248","DOI":"10.1152\/ajpgi.90223.2008","article-title":"Inflammasome-mediated regulation of hepatic stellate cells","volume":"296","author":"Watanabe","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.112789_bib46","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.4049\/jimmunol.1202733","article-title":"Histones activate the NLRP3 inflammasome in kupffer cells during sterile inflammatory liver injury","volume":"191","author":"Huang","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib48","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jhep.2011.01.048","article-title":"Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice","volume":"55","author":"Kamari","year":"2011","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib49","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2337\/db11-1389","article-title":"The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue","volume":"61","author":"Sun","year":"2012","journal-title":"Diabetes"},{"issue":"37","key":"10.1016\/j.biopha.2022.112789_bib50","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.biopha.2022.112789_bib51","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib52","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1189\/jlb.72.6.1084","article-title":"HMGB1 as a DNA-binding cytokine","volume":"72","author":"Andersson","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"51","key":"10.1016\/j.biopha.2022.112789_bib53","doi-asserted-by":"crossref","first-page":"39888","DOI":"10.1074\/jbc.M110.128348","article-title":"High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity","volume":"285","author":"Evankovich","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6894","key":"10.1016\/j.biopha.2022.112789_bib54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.112789_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-230X-12-45","article-title":"High mobility group B1 impairs hepatocyte regeneration in acetaminophen hepatotoxicity","volume":"12","author":"Yang","year":"2012","journal-title":"BMC Gastroenterol."},{"issue":"7","key":"10.1016\/j.biopha.2022.112789_bib56","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20042614","article-title":"The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion","volume":"201","author":"Tsung","year":"2005","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2022.112789_bib58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib59","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2022.112789_bib60","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1084\/jem.20070247","article-title":"HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling","volume":"204","author":"Tsung","year":"2007","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/SHK.0b013e3181f6aab0","article-title":"Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury","volume":"35","author":"Dhupar","year":"2011","journal-title":"Shock"},{"issue":"20","key":"10.1016\/j.biopha.2022.112789_bib62","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","article-title":"Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion","volume":"22","author":"Bonaldi","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2022.112789_bib63","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib64","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20045","article-title":"Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice","volume":"39","author":"Zeng","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","article-title":"Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells","volume":"52","author":"Guimaraes","year":"2010","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib66","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1182\/blood-2006-09-044776","article-title":"A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA","volume":"110","author":"Ivanov","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib67","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hep.23365","article-title":"Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury","volume":"51","author":"Bamboat","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"issue":"05","key":"10.1016\/j.biopha.2022.112789_bib69","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1055\/s-0029-1223987","article-title":"Non-alcoholic steatohepatitis sensitizes to TLR9-induced liver injury","volume":"47","author":"Csak","year":"2009","journal-title":"Z. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib70","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/ATVBAHA.117.309017","article-title":"STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity","volume":"37","author":"Mao","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"21","key":"10.1016\/j.biopha.2022.112789_bib71","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1073\/pnas.1911870117","article-title":"Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation","volume":"117","author":"Luther","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"41","key":"10.1016\/j.biopha.2022.112789_bib72","doi-asserted-by":"crossref","first-page":"16544","DOI":"10.1073\/pnas.1308331110","article-title":"STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease","volume":"110","author":"Petrasek","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib73","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s42003-020-0986-1","article-title":"Mitochondrial stress-activated cGAS-STING pathway inhibits thermogenic program and contributes to overnutrition-induced obesity in mice","volume":"3","author":"Bai","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2022.112789_bib74","article-title":"The cGAS-STING pathway: novel perspectives in liver diseases","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib75","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.112789_bib76","first-page":"414","article-title":"ATP release and purinergic signaling in NLRP3 inflammasome activation","volume":"3","author":"Gombault","year":"2012","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib77","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00424-006-0069-2","article-title":"P2 receptors: intracellular signaling","volume":"452","author":"Erb","year":"2006","journal-title":"Pflug. Arch."},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib78","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ni.2231","article-title":"Sensing and reacting to microbes through the inflammasomes","volume":"13","author":"Franchi","year":"2012","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2022.112789_bib79","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.freeradbiomed.2012.02.010","article-title":"P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice","volume":"52","author":"Chatterjee","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib80","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1517\/14728222.12.5.647","article-title":"The P2X7 receptor as a therapeutic target","volume":"12","author":"Romagnoli","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib81","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1172\/JCI40124","article-title":"Uric acid promotes an acute inflammatory response to sterile cell death in mice","volume":"120","author":"Kono","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib82","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11926-011-0162-1","article-title":"The role of uric acid as an endogenous danger signal in immunity and inflammation","volume":"13","author":"Ghaemi-Oskouie","year":"2011","journal-title":"Curr. Rheumatol. Rep."},{"issue":"7081","key":"10.1016\/j.biopha.2022.112789_bib83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biopha.2022.112789_bib84","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.200808-1274OC","article-title":"Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis","volume":"179","author":"Gasse","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"48","key":"10.1016\/j.biopha.2022.112789_bib85","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver","volume":"287","author":"Lanaspa","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib86","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/hep.23717","article-title":"Association between serum uric acid level and chronic liver disease in the United States","volume":"52","author":"Afzali","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.biopha.2022.112789_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011578","article-title":"High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study","volume":"5","author":"Xu","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib88","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism","volume":"64","author":"Wan","year":"2016","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib89","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","article-title":"Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds","volume":"62","author":"Xu","year":"2015","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib90","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib91","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib92","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib94","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4254\/wjh.v4.i6.184","article-title":"Regulation and deregulation of cholesterol homeostasis: The liver as a metabolic \u201cpower station\u201d","volume":"4","author":"Trapani","year":"2012","journal-title":"World J. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2022.112789_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajamaki","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2022.112789_bib96","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/eji.201041316","article-title":"Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis","volume":"41","author":"Freigang","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"7293","key":"10.1016\/j.biopha.2022.112789_bib97","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biopha.2022.112789_bib98","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1194\/jlr.M016246","article-title":"Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice","volume":"52","author":"Subramanian","year":"2011","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib99","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","article-title":"Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model","volume":"52","author":"Rector","year":"2010","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.biopha.2022.112789_bib101","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.joen.2012.09.023","article-title":"NLRP3 is expressed in human dental pulp cells and tissues","volume":"38","author":"Song","year":"2012","journal-title":"J. Endod."},{"key":"10.1016\/j.biopha.2022.112789_bib102","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/srep01077","article-title":"Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis","volume":"3","author":"Ding","year":"2013","journal-title":"Sci. Rep."},{"issue":"1 Suppl","key":"10.1016\/j.biopha.2022.112789_bib103","first-page":"S54","article-title":"Mutation of mitochondrial DNA in livers from patients with alcoholic hepatitis and nonalcoholic steatohepatitis","volume":"31","author":"Kawahara","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib104","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI59755","article-title":"The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation","volume":"122","author":"McGill","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.biopha.2022.112789_bib105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.it.2011.01.005","article-title":"Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation","volume":"32","author":"Krysko","year":"2011","journal-title":"Trends Immunol."},{"issue":"7285","key":"10.1016\/j.biopha.2022.112789_bib106","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib107","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.24501","article-title":"Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice","volume":"54","author":"Huang","year":"2011","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.biopha.2022.112789_bib108","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.2053","article-title":"Extracellular histones are major mediators of death in sepsis","volume":"15","author":"Xu","year":"2009","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib109","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.4049\/jimmunol.1003930","article-title":"Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury","volume":"187","author":"Xu","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054458","article-title":"Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma","volume":"8","author":"Rappa","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2022.112789_bib111","doi-asserted-by":"crossref","first-page":"G510","DOI":"10.1152\/ajpgi.00259.2015","article-title":"Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation","volume":"310","author":"Dattaroy","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib112","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.112789_bib113","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcp.2016.05.003","article-title":"The novel TLR9 antagonist COV08-0064 protects from ischemia\/reperfusion injury in non-steatotic and steatotic mice livers","volume":"112","author":"Shaker","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112789_bib114","doi-asserted-by":"crossref","first-page":"24399","DOI":"10.1038\/srep24399","article-title":"A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbagen.2013.09.018","article-title":"Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis","volume":"1840","author":"Zhou","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.biopha.2022.112789_bib116","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1189\/jlb.3A0114-005RR","article-title":"Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation","volume":"96","author":"Honda","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib117","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.biopha.2022.112789_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107265","article-title":"IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis","volume":"9","author":"Negrin","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2022.112789_bib119","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm.3423","article-title":"IL-17 producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity","volume":"20","author":"Kim","year":"2014","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.biopha.2022.112789_bib120","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"New. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib121","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2022.112789_bib122","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.23167","article-title":"Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis","volume":"50","author":"Witek","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib123","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.24747","article-title":"A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis","volume":"55","author":"Ratziu","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2022.112789_bib124","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/liv.12570","article-title":"The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis","volume":"35","author":"Barreyro","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2022.112789_bib125","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/ijo.2016.74","article-title":"Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis (NASH) and hepatic fibrosis in LDLR-\/-.Leiden mice","volume":"40","author":"Morrison","year":"2016","journal-title":"Int. J. Obes."},{"issue":"2","key":"10.1016\/j.biopha.2022.112789_bib126","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbrc.2020.03.034","article-title":"Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING","volume":"526","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:38:55Z","timestamp":1781764735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222001779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":126,"alternative-id":["S0753332222001779"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112789","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of sterile inflammation to the fatty liver disease and the potential therapies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112789"}}